Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Joanna, Lem"'
Publikováno v:
International Journal of Clinical Pharmacy. 44:608-618
Background To support reclassification in the UK of sildenafil citrate (50 mg) from prescription-only medicine to a pharmacy medicine (P status) under the brand name “Viagra Connect®”, additional risk minimisation measures were implemented that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c984bed5439d165e836feb82c7365c94
https://doi.org/10.1007/s11096-021-01339-7
https://doi.org/10.1007/s11096-021-01339-7
Publikováno v:
International journal of clinical pharmacy. 44(3)
Background To support reclassification in the UK of sildenafil citrate (50 mg) from prescription-only medicine to a pharmacy medicine (P status) under the brand name "Viagra Connect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5deae251e44a388750327be9f3947dfd
https://pubmed.ncbi.nlm.nih.gov/35380395
https://pubmed.ncbi.nlm.nih.gov/35380395
Autor:
Anne Lewis, Jalal A. Aram, Rachel E. Sobel, Shahrzad Moosavi, Klaus Freivogel, Joanna Lem, Muhammad Younus
Publikováno v:
Pharmaceutical medicine. 33(2)
Voriconazole is an extended-spectrum antifungal agent approved for the treatment and prophylaxis of invasive aspergillosis and other serious fungal infections. In 2014, additional risk minimization measures (aRMM) consisting of a Healthcare Professio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e19b14d292df66f5c56448487d36c3d
https://pubmed.ncbi.nlm.nih.gov/31933256
https://pubmed.ncbi.nlm.nih.gov/31933256
Autor:
Gary G. Koch, Daniel O. Koralek, Robert A. Wise, Michael B. Bracken, Roger B. Cohen, Sol Klioze, William T. Duggan, Jackson Neville Colin, Joanna Lem, Nicolle M. Gatto
Publikováno v:
Diabetes care. 42(9)
OBJECTIVEThe Follow-Up Study of patients previously enrolled in Exubera controlled clinical trials (FUSE) was designed to evaluate whether patients previously treated with Exubera (EXU; insulin human [rDNA origin], inhaled powder) in controlled clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd145d5499713efe8b88638a14518e7
https://pubmed.ncbi.nlm.nih.gov/31331907
https://pubmed.ncbi.nlm.nih.gov/31331907
Autor:
Claudia Maturo, Zuzana Zachar, James F. Marecek, Robert Shorr, Joanna Lem, Sameer Karnik, Paul M. Bingham, Sunita Gupta, Shawn D. Stuart, Robert J. Rodriguez, Alexandra Schauble, Katy Howell, Arin Piramzadian, King Lee
Publikováno v:
Journal of Molecular Medicine. 89:1137-1148
We report the analysis of CPI-613, the first member of a large set of analogs of lipoic acid (lipoate) we have investigated as potential anticancer agents. CPI-613 strongly disrupts mitochondrial metabolism, with selectivity for tumor cells in cultur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f4b2975b6c03fe6a8dafe37ce1655a
https://doi.org/10.1007/s00109-011-0785-8
https://doi.org/10.1007/s00109-011-0785-8
Publikováno v:
Drug safety. 34(10)
Post-approval, observational drug safety studies face well known difficulties in controlling for confounding, particularly confounding by indication for drug use. A study design that addresses confounding by indication is the large simple trial (LST)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::468af21e07166f658f2509bbec3983b6
https://pubmed.ncbi.nlm.nih.gov/21879776
https://pubmed.ncbi.nlm.nih.gov/21879776